MCRB Return on Tangible Equity | Seres Therapeutics, Inc.

Seres Therapeutics, Inc. (MCRB) Return on Tangible Equity

2026-06-30: Return Tang Equity -65.05%.
2026-03-31: Return Tang Equity -176.98%.
2025-12-31: Return Tang Equity 12.88%.
2025-09-30: Return Tang Equity 12.34%.

Complete source-backed return tang equity history.

Available history: 2013-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-65.05%
2026-03-31	-176.98%
2025-12-31	12.88%
2025-09-30	12.34%
2025-06-30	260.90%
2025-03-31	144.56%
2024-12-31	0.99%
2024-09-30	-106.51%
2024-06-30	186.17%
2024-03-31	138.41%
2023-12-31	253.53%
2023-09-30	934.15%
2023-06-30	-678.43%
2023-03-31	552.96%
2022-12-31	-2319.92%
2022-09-30	-342.33%
2022-06-30	-447.32%
2022-03-31	-107.14%
2021-12-31	-49.87%
2021-09-30	-19.25%
2021-06-30	-130.93%
2021-03-31	-72.87%
2020-12-31	-51.00%
2020-09-30	-47.67%
2020-06-30	115.57%
2020-03-31	106.78%
2019-12-31	145.43%
2019-09-30	225.92%
2019-06-30	435.93%
2019-03-31	136.55%
2018-12-31	205.94%
2018-09-30	348.79%
2018-06-30	691.22%
2018-03-31	-915.14%
2017-12-31	-147.25%
2017-09-30	-100.22%
2017-06-30	-110.83%
2017-03-31	-87.35%
2016-12-31	-69.05%
2016-09-30	-55.81%
2016-06-30	-48.91%
2016-03-31	-35.04%
2015-12-31	-28.90%
2015-09-30	-21.56%
2015-06-30	-39.46%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	12.88%
2024-12-31	0.99%
2023-12-31	253.53%
2022-12-31	-2319.92%
2021-12-31	-49.87%
2020-12-31	-51.00%
2019-12-31	145.43%
2018-12-31	205.94%
2017-12-31	-147.25%
2016-12-31	-69.05%
2015-12-31	-26.67%
2014-12-31	62.53%
2013-12-31	54.89%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
MIRA PHARMACEUTICALS, INC. (MIRA)	United States	$0.036B	-4.30
BriaCell Therapeutics Corp. (BCTX)		$0.037B
PMGC Holdings Inc. (ELAB)	United States	$0.037B
FILANA THERAPEUTICS, INC. (FLNA)	United States	$0.038B	-1.05
Actinium Pharmaceuticals, Inc. (ATNM)	United States	$0.038B	2.73
ROCKWELL MEDICAL, INC. (RMTI)	United States	$0.035B
Celularity Inc (CELU)	United States	$0.038B	-0.34
CervoMed Inc. (CRVO)	United States	$0.038B	-1.39
Context Therapeutics Inc. (CNTX)	United States	$0.034B	-1.10
Edesa Biotech, Inc. (EDSA)	Canada	$0.039B